Your cart
Close Alternative Icon
Close Icon
Down Arrow Icon

Research a Condition

At The CBD Curators, we are not doctors; however, it may be helpful for some people who may wish to do their own research into CBD and various specific ailments.  The list below is meant to provide a guide. 

Cannabidiol (CBD) has exploded into the world of health and wellness. With dozens of natural benefits, CBD has been used to ease conditions such as anxietyepilepsyneurodegenerative diseases and more. For the last century, researchers have assessed CBD as a treatment for numerous conditions. More than 50, in fact. What these studies show is profound. If you are looking for research on CBD benefits for a certain condition, you will find it here. From mental health to MS, we have gathered a collection of more than 250 resources, organized by condition.

 

CBD FOR ACNE

Cannabidiol as a Treatment for Acne?

CBD FOR ACNE

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

CBD FOR ACNE

The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities

CBD FOR ACNE

Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling

CBD FOR ACNE

Endocannabinoid signaling and epidermal differentiation

6

CBD FOR ADD / ADHD

Searching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders

CBD FOR ADD / ADHD

Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats

CBD FOR ADD / ADHD

Subtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use

CBD FOR ADD / ADHD

Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students

CBD FOR ADD / ADHD

Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report

CBD FOR ADD / ADHD

Fitness to drive in spite (because) of THC

10

CBD FOR ADDICTION

Cannabidiol reduces cigarette consumption in tobacco smokers

CBD FOR ADDICTION

Cannabidiol inhibits the reward-facilitating effect of morphine

CBD FOR ADDICTION

Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances

CBD FOR ADDICTION

Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats

CBD FOR ADDICTION

Impact of Cannabis Use during Stabilization on Methadone Maintenance Treatment

CBD FOR ADDICTION

Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010

CBD FOR ADDICTION

Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents

CBD FOR ADDICTION

Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity

CBD FOR ADDICTION

Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder

CBD FOR ADDICTION

Cannabidiol for the treatment of cannabis withdrawal syndrome

4

CBD FOR ALS

Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials

CBD FOR ALS

ALS: delayed disease progression in mice by treatment with a cannabinoid

CBD FOR ALS

The (Endo)Cannabinoid System in Multiple Sclerosis and ALS

CBD FOR ALS

Survey of cannabis use in patients with ALS

16

CBD FOR ALZHEIMERS

The therapeutic potential of the endocannabinoid system for Alzheimer’s disease

CBD FOR ALZHEIMERS

Endocannabinoid signalling in Alzheimer’s disease

CBD FOR ALZHEIMERS

A molecular link between the active component of marijuana and Alzheimer’s disease pathology

CBD FOR ALZHEIMERS

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

CBD FOR ALZHEIMERS

The Potential Therapeutic Effects of THC on Alzheimer’s Disease

CBD FOR ALZHEIMERS

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease

CBD FOR ALZHEIMERS

Cannabinoids for the treatment of dementia

CBD FOR ALZHEIMERS

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

CBD FOR ALZHEIMERS

Cannabidiol: A promising drug for neurodegenerative disorders?

CBD FOR ALZHEIMERS

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition

CBD FOR ALZHEIMERS

The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses

CBD FOR ALZHEIMERS

The role of phytochemicals in the treatment and prevention of dementia

CBD FOR ALZHEIMERS

Cannabinoids for the treatment of dementia

CBD FOR ALZHEIMERS

Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement

CBD FOR ALZHEIMERS

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

CBD FOR ALZHEIMERS

Can Marijuana Prevent Alzheimer’s?

4

CBD FOR ANOREXIA

Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa

CBD FOR ANOREXIA

The role of the endocannabinoid system in eating disorders: Neurochemical and behavioural preclinical evidence

CBD FOR ANOREXIA

Cancer cachexia and cannabinoids

CBD FOR ANOREXIA

Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa

9

CBD FOR ANXIETY

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

CBD FOR ANXIETY

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa

CBD FOR ANXIETY

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

CBD FOR ANXIETY

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder

CBD FOR ANXIETY

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation

CBD FOR ANXIETY

Effects of cannabidiol (CBD) on regional cerebral blood flow

CBD FOR ANXIETY

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

CBD FOR ANXIETY

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

CBD FOR ANXIETY

Plant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence

4

CBD FOR ATHEROSCLEROSIS

The role of the endocannabinoid system in atherosclerosis

CBD FOR ATHEROSCLEROSIS

Cannabinoid receptors in atherosclerosis

CBD FOR ATHEROSCLEROSIS

The potential use of cannabidiol in the therapy of metabolic syndrome

CBD FOR ATHEROSCLEROSIS

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

4

CBD FOR ARTHRITIS

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis

CBD FOR ARTHRITIS

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

CBD FOR ARTHRITIS

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55

CBD FOR ARTHRITIS

Arthritis and cannabinoids

5

CBD FOR ASTHMA

The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke

CBD FOR ASTHMA

Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma

CBD FOR ASTHMA

Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs

CBD FOR ASTHMA

Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways

CBD FOR ASTHMA

Bronchodilator effect of delta1-tetrahydrocannabinol

5

CBD FOR AUTISM

Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain

CBD FOR AUTISM

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders

CBD FOR AUTISM

A novel approach to the symptomatic treatment of autism

CBD FOR AUTISM

Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders

CBD FOR AUTISM

Targeting the endocannabinoid system in the treatment of fragile X syndrome

5

CBD FOR BIPOLAR AFFECTIVE DISORDER

Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential

CBD FOR BIPOLAR AFFECTIVE DISORDER

Cannabidiol was ineffective for manic episode of bipolar affective disorder

CBD FOR BIPOLAR AFFECTIVE DISORDER

Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar Disorder After a First Hospitalization for Mania

CBD FOR BIPOLAR AFFECTIVE DISORDER

Does Cannabis Use Affect Treatment Outcome in Bipolar Disorder?: A Longitudinal Analysis

CBD FOR BIPOLAR AFFECTIVE DISORDER

The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder: Anecdotal Evidence and the Need for Clinical Research

5

CBD FOR CANCER - GENERAL

Cannabidiol as potential anticancer drug

CBD FOR CANCER - GENERAL

Cannabidiol inhibits angiogenesis by multiple mechanisms

CBD FOR CANCER - GENERAL

The inhibitory effects of cannabidiol on systemic malignant tumors

CBD FOR CANCER - GENERAL

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1

CBD FOR CANCER - GENERAL

Marijuana fights cancer and helps manage side effects

4

CBD FOR CANCER - LUNG

Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1C

CBD FOR CANCER - LUNG

COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells

CBD FOR CANCER - LUNG

Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells

CBD FOR CANCER - LUNG

Media ignored expert’s shocking findings that marijuana helps prevent lung cancer

5

CBD FOR CANCER - PROSTATE/COLON

Towards the use of non-psychoactive cannabinoids for prostate cancer

CBD FOR CANCER - PROSTATE/COLON

In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines

CBD FOR CANCER - PROSTATE/COLON

Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent

CBD FOR CANCER - PROSTATE/COLON

Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer

CBD FOR CANCER - PROSTATE/COLON

Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol

5

CBD FOR CANCER - BREAST

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

CBD FOR CANCER - BREAST

Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy

CBD FOR CANCER - BREAST

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

CBD FOR CANCER - BREAST

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

CBD FOR CANCER - BREAST

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration

8

CBD FOR CANCER - BRAIN

Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival

CBD FOR CANCER - BRAIN

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines(PubMed)

CBD FOR CANCER - BRAIN

Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas

CBD FOR CANCER - BRAIN

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism

CBD FOR CANCER - BRAIN

Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target

CBD FOR CANCER - BRAIN

Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents

CBD FOR CANCER - BRAIN

Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect

CBD FOR CANCER - BRAIN

Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme

4

CBD FOR CANCER - LEUKEMIA

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression

CBD FOR CANCER - LEUKEMIA

Cannabidiol-Induced Apoptosis in Human Leukemia Cells

CBD FOR CANCER - LEUKEMIA

Cannabidiol Reduces Leukemic Cell Size – But Is It Important?

CBD FOR CANCER - LEUKEMIA

Targeting cannabinoid receptors to treat leukemia

4

CBD FOR CANCER - SKIN

Anticancer activity of anandamide in human cutaneous melanoma cells

CBD FOR CANCER - SKIN

Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpes virus-infected endothelium (PubMed)

CBD FOR CANCER - SKIN

Cannabinoid receptors as novel targets for the treatment of melanoma

CBD FOR CANCER - SKIN

The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development

4

CBD FOR CANCER - ENDOCRINE

Endocannabinoids in endocrine and related tumours

CBD FOR CANCER - ENDOCRINE

A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells

CBD FOR CANCER - ENDOCRINE

Cannabinoids in pancreatic cancer: Correlation with survival and pain

CBD FOR CANCER - ENDOCRINE

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma

4

CBD FOR CANCER - BLADDER

TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer

CBD FOR CANCER - BLADDER

Association Between Cannabis Use and the Risk of Bladder Cancer

CBD FOR CANCER - BLADDER

Inhibitory Effect of Standardized Cannabis sativaExtract and Its Ingredient Cannabidiol on Rat and Human Bladder Contractility

CBD FOR CANCER - BLADDER

Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism

4

CBD FOR CANCER - PAIN RELIEF

Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain

CBD FOR CANCER - PAIN RELIEF

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial

CBD FOR CANCER - PAIN RELIEF

Marijuana extract helps prevent chemo pain

CBD FOR CANCER - PAIN RELIEF

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics

10

CBD FOR CROHNS & COLITIS

Cannabidiol in inflammatory bowel diseases: a brief overview

CBD FOR CROHNS & COLITIS

Cannabis finds its way into treatment of Crohn’s disease

CBD FOR CROHNS & COLITIS

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

CBD FOR CROHNS & COLITIS

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

CBD FOR CROHNS & COLITIS

The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis

CBD FOR CROHNS & COLITIS

Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice

CBD FOR CROHNS & COLITIS

Cannabinoids and the gut: New developments and emerging concepts

CBD FOR CROHNS & COLITIS

Endocannabinoids and the gastrointestinal tract

CBD FOR CROHNS & COLITIS

Cannabinoids and gastrointestinal motility: Animal and human studies

CBD FOR CROHNS & COLITIS

Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis

11

CBD FOR DEPRESSION

Endocannabinoid system dysfunction in mood and related disorders

CBD FOR DEPRESSION

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa

CBD FOR DEPRESSION

The endocannabinoid system and the treatment of mood and anxiety disorders

CBD FOR DEPRESSION

Endocannabinoid signaling in the etiology and treatment of major depressive illness

CBD FOR DEPRESSION

Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors

CBD FOR DEPRESSION

Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants

CBD FOR DEPRESSION

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa

CBD FOR DEPRESSION

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress

CBD FOR DEPRESSION

Serum contents of endocannabinoids are correlated with blood pressure in depressed women

CBD FOR DEPRESSION

The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants

CBD FOR DEPRESSION

Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures

21

CBD FOR ENDOCRINE DISORDERS

Endocannabinoid system participates in neuroendocrine control of homeostasis

CBD FOR ENDOCRINE DISORDERS

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

CBD FOR ENDOCRINE DISORDERS

Endocannabinoids in endocrine and related tumours

CBD FOR ENDOCRINE DISORDERS

Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas

CBD FOR ENDOCRINE DISORDERS

The role of the endocannabinoid system in the neuroendocrine regulation of energy balance

CBD FOR ENDOCRINE DISORDERS

CBD for children with Dravet’s and intractable seizures

CBD FOR ENDOCRINE DISORDERS

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

CBD FOR ENDOCRINE DISORDERS

Medicinal marijuana stops seizures, brings hope to a little girl

CBD FOR ENDOCRINE DISORDERS

Cannabinoids for epilepsy

CBD FOR ENDOCRINE DISORDERS

Cannabis, cannabidiol, and epilepsy – From receptors to clinical response

CBD FOR ENDOCRINE DISORDERS

The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability

CBD FOR ENDOCRINE DISORDERS

Chronic administration of cannabidiol to healthy volunteers and epileptic patients

CBD FOR ENDOCRINE DISORDERS

Endocannabinoid system protects against cryptogenic seizures

CBD FOR ENDOCRINE DISORDERS

Seizing an opportunity for the endocannabinoid system

CBD FOR ENDOCRINE DISORDERS

Cannabidiol: promise and pitfalls

CBD FOR ENDOCRINE DISORDERS

Cannabidivarin (CBDV) suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression

CBD FOR ENDOCRINE DISORDERS

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

CBD FOR ENDOCRINE DISORDERS

Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo

CBD FOR ENDOCRINE DISORDERS

Hypnotic and antiepileptic effects of cannabidiol

CBD FOR ENDOCRINE DISORDERS

The cannabinoids as potential antiepileptics

CBD FOR ENDOCRINE DISORDERS

Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats

5

CBD FOR FIBROMYALGIA

Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

CBD FOR FIBROMYALGIA

Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life

CBD FOR FIBROMYALGIA

Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia

CBD FOR FIBROMYALGIA

Cannabinoids for fibromyalgia

CBD FOR FIBROMYALGIA

Medical Cannabis for the Treatment of Fibromyalgia

4

CBD FOR GLAUCOMA

Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite

CBD FOR GLAUCOMA

Cannabinoids and glaucoma

CBD FOR GLAUCOMA

The treatment of glaucoma using a non-psychoactive preparation of Cannabis sativa

CBD FOR GLAUCOMA

Cannabinoids for treatment of glaucoma

7

CBD FOR HEART DISEASE

Is the cardiovascular system a therapeutic target for cannabidiol?

CBD FOR HEART DISEASE

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion

CBD FOR HEART DISEASE

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy

CBD FOR HEART DISEASE

The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias: The Role of Adenosine A1 Receptors

CBD FOR HEART DISEASE

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

CBD FOR HEART DISEASE

Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension

CBD FOR HEART DISEASE

Oleamide: A fatty acid amide signaling molecule in the cardiovascular system?

6

CBD FOR HUNTINGTONS DISEASE

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease

CBD FOR HUNTINGTONS DISEASE

Cannabinoids: Novel medicines for the treatment of Huntington’s disease

CBD FOR HUNTINGTONS DISEASE

Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington’s disease: role of CB(1) and CB(2) receptors

CBD FOR HUNTINGTONS DISEASE

Controlled clinical trial of cannabidiol in Huntington’s disease

CBD FOR HUNTINGTONS DISEASE

Prospects for cannabinoid therapies in basal ganglia disorders

CBD FOR HUNTINGTONS DISEASE

Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

13

CBD FOR INFLAMMATION

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

CBD FOR INFLAMMATION

The endocannabinoid system: an emerging key player in inflammation

CBD FOR INFLAMMATION

Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice

CBD FOR INFLAMMATION

Cannabinoids, endocannabinoids, and related analogs in inflammation

CBD FOR INFLAMMATION

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor

CBD FOR INFLAMMATION

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

CBD FOR INFLAMMATION

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

CBD FOR INFLAMMATION

Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation

CBD FOR INFLAMMATION

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

CBD FOR INFLAMMATION

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

CBD FOR INFLAMMATION

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

CBD FOR INFLAMMATION

Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

CBD FOR INFLAMMATION

Cannabinoids in clinical practice

9

CBD FOR IRRITABLE BOWEL SYNDROME

Cannabidiol in inflammatory bowel diseases: A brief overview

CBD FOR IRRITABLE BOWEL SYNDROME

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

CBD FOR IRRITABLE BOWEL SYNDROME

Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

CBD FOR IRRITABLE BOWEL SYNDROME

Cannabinoid actions at TRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation

CBD FOR IRRITABLE BOWEL SYNDROME

Therapeutic potential of cannabinoid-based drugs

CBD FOR IRRITABLE BOWEL SYNDROME

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology)

CBD FOR IRRITABLE BOWEL SYNDROME

Cannabinoids and the gut: New developments and emerging concepts

CBD FOR IRRITABLE BOWEL SYNDROME

Endocannabinoids and the gastrointestinal tract

CBD FOR IRRITABLE BOWEL SYNDROME

Cannabinoids and gastrointestinal motility: Animal and human studies

4

CBD FOR KIDNEY DISEASE

Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

CBD FOR KIDNEY DISEASE

Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay

CBD FOR KIDNEY DISEASE

Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?

CBD FOR KIDNEY DISEASE

The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases

7

CBD FOR LIVER DISEASE

The endocannabinoid system and liver diseases

CBD FOR LIVER DISEASE

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death

CBD FOR LIVER DISEASE

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis

CBD FOR LIVER DISEASE

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats

CBD FOR LIVER DISEASE

Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol

CBD FOR LIVER DISEASE

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice

CBD FOR LIVER DISEASE

Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation

5

CBD FOR METABOLIC SYNDROME

The impact of marijuana use on glucose, insulin, and insulin resistance among US adults

CBD FOR METABOLIC SYNDROME

The potential use of cannabidiol in the therapy of metabolic syndrome

CBD FOR METABOLIC SYNDROME

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes

CBD FOR METABOLIC SYNDROME

Metabolic syndrome in people with a psychotic illness: is cannabis protective?

CBD FOR METABOLIC SYNDROME

Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome

5

CBD FOR MIGRAINES

Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

CBD FOR MIGRAINES

Effects of anandamide in migraine: data from an animal model

CBD FOR MIGRAINES

Cannabinoids and hallucinogens for headache

CBD FOR MIGRAINES

The endocannabinoid system and migraine

CBD FOR MIGRAINES

Variations in the cannabinoid receptor 1 gene predispose to migraine

6

CBD FOR MOOD DISORDERS

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

CBD FOR MOOD DISORDERS

The endocannabinoid system and the treatment of mood and anxiety disorders

CBD FOR MOOD DISORDERS

The endocannabinoid system and psychiatric disorders

CBD FOR MOOD DISORDERS

The endocannabinoid system in the regulation of emotions throughout lifespan: A discussion on therapeutic perspectives

CBD FOR MOOD DISORDERS

Endocannabinoid system dysfunction in mood and related disorders

CBD FOR MOOD DISORDERS

Effects of cannabidiol (CBD) on regional cerebral blood flow

3

CBD FOR MOTION SICKNESS

Motion sickness, stress and the endocannabinoid system

CBD FOR MOTION SICKNESS

Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system

CBD FOR MOTION SICKNESS

The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis

10

CBD FOR MULTIPLE SCLEROSIS

Sativex for the management of multiple sclerosis symptoms

CBD FOR MULTIPLE SCLEROSIS

THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis

CBD FOR MULTIPLE SCLEROSIS

Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity

CBD FOR MULTIPLE SCLEROSIS

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

CBD FOR MULTIPLE SCLEROSIS

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial

CBD FOR MULTIPLE SCLEROSIS

Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis

CBD FOR MULTIPLE SCLEROSIS

Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis

CBD FOR MULTIPLE SCLEROSIS

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

CBD FOR MULTIPLE SCLEROSIS

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain(

CBD FOR MULTIPLE SCLEROSIS

Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

6

CBD FOR NAUSEA

Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus

CBD FOR NAUSEA

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation

CBD FOR NAUSEA

Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews

CBD FOR NAUSEA

Regulation of nausea and vomiting by cannabinoids

CBD FOR NAUSEA

Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats

CBD FOR NAUSEA

Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting

5

CBD FOR NEURODEGENERATION

Cannabidiol: A promising drug for neurodegenerative disorders?

CBD FOR NEURODEGENERATION

Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?

CBD FOR NEURODEGENERATION

Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder

CBD FOR NEURODEGENERATION

Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders

CBD FOR NEURODEGENERATION

Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection

18

CBD FOR NEUROPATHIC PAIN

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain

CBD FOR NEUROPATHIC PAIN

Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

CBD FOR NEUROPATHIC PAIN

Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine

CBD FOR NEUROPATHIC PAIN

Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial

CBD FOR NEUROPATHIC PAIN

Cannabinoids for neuropathic pain

CBD FOR NEUROPATHIC PAIN

Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue

CBD FOR NEUROPATHIC PAIN

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial

CBD FOR NEUROPATHIC PAIN

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

CBD FOR NEUROPATHIC PAIN

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

CBD FOR NEUROPATHIC PAIN

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy

CBD FOR NEUROPATHIC PAIN

Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved

CBD FOR NEUROPATHIC PAIN

Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action

CBD FOR NEUROPATHIC PAIN

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

CBD FOR NEUROPATHIC PAIN

Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes

CBD FOR NEUROPATHIC PAIN

Cannabinoids in the management of difficult to treat pain

CBD FOR NEUROPATHIC PAIN

Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain

CBD FOR NEUROPATHIC PAIN

Marijuana extract helps prevent chemo pain

CBD FOR NEUROPATHIC PAIN

Pot users less likely to take painkillers

6

CBD FOR OBESITY

The impact of marijuana use on glucose, insulin, and insulin resistance among US adults

CBD FOR OBESITY

Cannabinol and cannabidiol exert opposing effects on rat feeding patterns

CBD FOR OBESITY

Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?

CBD FOR OBESITY

The endocannabinoid system in obesity and type 2 diabetes

CBD FOR OBESITY

Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk

CBD FOR OBESITY

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes

3

CBD FOR OCD

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour (PubMed)

CBD FOR OCD

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

CBD FOR OCD

Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice

7

CBD FOR PARKINSONS DISEASE

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

CBD FOR PARKINSONS DISEASE

Prospects for cannabinoid therapies in basal ganglia disorders

CBD FOR PARKINSONS DISEASE

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties

CBD FOR PARKINSONS DISEASE

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease

CBD FOR PARKINSONS DISEASE

Cannabidiol for the treatment of psychosis in Parkinson’s disease

CBD FOR PARKINSONS DISEASE

Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease

CBD FOR PARKINSONS DISEASE

Therapeutic potential of cannabinoids in CNS disease

3

CBD FOR PRION

Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity

CBD FOR PRION

Cannabidiol: A prion therapy for mice?

CBD FOR PRION

Alteration of the endocannabinoid system in mouse brain during prion disease

13

CBD FOR PTSD

The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD

CBD FOR PTSD

Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks

CBD FOR PTSD

Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear

CBD FOR PTSD

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors

CBD FOR PTSD

Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis

CBD FOR PTSD

Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

CBD FOR PTSD

Cannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment

CBD FOR PTSD

The endocannabinoid system and extinction learning

CBD FOR PTSD

A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers

CBD FOR PTSD

Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit

CBD FOR PTSD

Non-antidepressant long-term treatment in post-traumatic stress disorder

CBD FOR PTSD

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system

CBD FOR PTSD

Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors

4

CBD FOR RHEUMATISM

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

CBD FOR RHEUMATISM

Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases

CBD FOR RHEUMATISM

Clinical Implications for Cannabinoid Use in the Rheumatic Diseases

CBD FOR RHEUMATISM

Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases

12

CBD FOR SCHIZOPHRENIA

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

CBD FOR SCHIZOPHRENIA

Cannabidiol as a potential treatment for psychosis

CBD FOR SCHIZOPHRENIA

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

CBD FOR SCHIZOPHRENIA

Medical use of cannabis. Cannabidiol: A new light for schizophrenia?

CBD FOR SCHIZOPHRENIA

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

CBD FOR SCHIZOPHRENIA

Peripheral endocannabinoid system dysregulation in first-episode psychosis

CBD FOR SCHIZOPHRENIA

Cannabinoids and schizophrenia: Therapeutic prospects

CBD FOR SCHIZOPHRENIA

Antipsychotic-like effects of cannabidiol and rimonabant: Systematic review of animal and human studies

CBD FOR SCHIZOPHRENIA

Cannabidiol monotherapy for treatment-resistant schizophrenia

CBD FOR SCHIZOPHRENIA

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

CBD FOR SCHIZOPHRENIA

Marijuana compound treats schizophrenia with few side effects: Clinical trial

CBD FOR SCHIZOPHRENIA

Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?

3

CBD FOR SICKLE CELL ANEMIA

Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids

CBD FOR SICKLE CELL ANEMIA

Cannabis use in sickle cell disease: A questionnaire study

CBD FOR SICKLE CELL ANEMIA

Cannabinoid Receptor-Specific Mechanisms To Alleviate Pain In Sickle Cell Anemia Via Inhibition Of Mast Cell Activation And Neurogenic Inflammation

8

CBD FOR SKIN CONDITIONS

Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis

CBD FOR SKIN CONDITIONS

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

CBD FOR SKIN CONDITIONS

The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities

CBD FOR SKIN CONDITIONS

Epigenetic control of skin differentiation genes by phytocannabinoids

CBD FOR SKIN CONDITIONS

Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1

CBD FOR SKIN CONDITIONS

Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation

CBD FOR SKIN CONDITIONS

Attenuation of allergic contact dermatitis through the endocannabinoid system

CBD FOR SKIN CONDITIONS

Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus

7

CBD FOR SLEEP DISORDERS

The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent

CBD FOR SLEEP DISORDERS

Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine

CBD FOR SLEEP DISORDERS

Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats

CBD FOR SLEEP DISORDERS

Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults

CBD FOR SLEEP DISORDERS

Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats

CBD FOR SLEEP DISORDERS

Endocannabinoid modulation of cortical up-states and NREM sleep

CBD FOR SLEEP DISORDERS

Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat

4

CBD FOR SPINAL CORD INJURY

Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury

CBD FOR SPINAL CORD INJURY

Cannabis effect on spasticity in spinal cord injury

CBD FOR SPINAL CORD INJURY

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease

CBD FOR SPINAL CORD INJURY

Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury

13

CBD FOR STRESS

Endogenous cannabinoid signaling is essential for stress adaptation

CBD FOR STRESS

Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders

CBD FOR STRESS

Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output

CBD FOR STRESS

Neuromodulators, stress and plasticity: a role for endocannabinoid signalling

CBD FOR STRESS

Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress

CBD FOR STRESS

Endocannabinoids and stress

CBD FOR STRESS

Stress regulates endocannabinoid-CB1 receptor signaling

CBD FOR STRESS

Chronic Stress Impairs α1-Adrenoceptor-Induced Endocannabinoid-Dependent Synaptic Plasticity in the Dorsal Raphe Nucleus

CBD FOR STRESS

Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance

CBD FOR STRESS

Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression

CBD FOR STRESS

Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory

CBD FOR STRESS

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

CBD FOR STRESS

Low-frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid

6

CBD FOR STROKE/TBI

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

CBD FOR STROKE/TBI

Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism

CBD FOR STROKE/TBI

Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism (

CBD FOR STROKE/TBI

Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function

CBD FOR STROKE/TBI

Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice

CBD FOR STROKE/TBI

Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance

  

[1] https://cbdorigin.com/cbd-benefits-many-conditions/